Praxis Precision Medicines, Inc.
NASDAQ:PRAXBiotechnology
Healthcare
$310.90 +4.49%
+$12.13 today
- Market cap
- $8.69B
- Beta
- 2.75
- P/E (TTM)
- -25.0
- EPS (TTM)
- -$11.31
52W Low $37.19High $366.52
Volume 0.63M
Average 0.45M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$249.07M
FY 2025 · Annual
Investing Cash Flow
-$311.15M
FY 2025 · Annual
Financing Cash Flow
$702.17M
FY 2025 · Annual
+36.5% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (167.06M) | (214.03M) | (123.28M) | (182.82M) | (303.27M) |
| Depreciation & Amortization | 182K | 419K | 432K | 358K | 140K |
| Deferred Income Tax | 2.09M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 22.69M | 28.59M | 24.86M | 41.36M | 33.94M |
| Change in Working Capital | 16.13M | (1.78M) | (13.03M) | 10.92M | 22.68M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 7.27M | 3.89M | (8.86M) | 6.71M | 12.1M |
| Other Working Capital | 8.87M | (5.67M) | (4.17M) | 4.21M | 10.58M |
| Other Non-Cash Items | 1.41M | 1.76M | (121K) | (1.58M) | (2.56M) |
| Operating Cash Flow | (124.55M) | (185.04M) | (111.14M) | (131.76M) | (249.07M) |
| Capital Expenditures | (1.05M) | (444K) | (50K) | 0 | (56K) |
| Acquisitions (Net) | 139.47M | (97.33M) | 0 | 0 | 0 |
| Purchases of Investments | (164.17M) | (83.02M) | 0 | (371.52M) | (623.81M) |
| Sales of Investments | 24.7M | 180.36M | 39M | 123.03M | 312.72M |
| Other Investing Activities | (139.47M) | 97.33M | 0 | 0 | 0 |
| Investing Cash Flow | (140.52M) | 96.89M | 38.95M | (248.49M) | (311.15M) |
| Debt Repayment | (763K) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 105.71M | 9.56M | 91.59M | 512M | 704.26M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.64M | 904K | 279K | 2.33M | (2.09M) |
| Financing Cash Flow | 107.59M | 10.47M | 91.87M | 514.32M | 702.17M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (157.49M) | (77.69M) | 19.69M | 134.07M | 141.96M |
| Free Cash Flow | (125.6M) | (185.49M) | (111.19M) | (131.76M) | (249.12M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$303.3M
+ D&A$140.0K
+ Stock-Based Comp$33.9M
+ Deferred Tax$0
+ Working Capital$22.7M
- Other Non-Cash-$2.6M
= Operating Cash Flow-$249.1M
- Capex-$56.0K
= Free Cash Flow-$249.1M
Analysis
FY2025 free cash flow is -$249.1M. FCF conversion is 82.1% of net income. Operating cash flow was -$249.1M, with capex of -$56.0K. The largest bridge item is Stock-Based Comp at $33.9M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 5, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 |
Does PRAX generate free cash flow?
Praxis Precision Medicines, Inc. (PRAX) generated -$249.12M of free cash flow in fiscal 2025.
How much operating cash flow does PRAX produce?
Operating cash flow was -$249.07M, before capital expenditures of $56,000.00.
Continue the stock analysis
Jump to another research area for this company.